Nebraska Medicaid does not cover weight loss drugs. The state’s Department of Health and Human Services explicitly excludes “drugs or items prescribed or recommended for weight control and/or appetite suppression” from covered services,1Nebraska DHHS. Medicaid Services and the same exclusion carries through the managed care plans, including Nebraska Total Care, which lists “drugs used for weight loss” among its excluded drug categories.2Nebraska Total Care. Nebraska Total Care Formulary That means Wegovy, Saxenda, Zepbound, and similar medications are not paid for when the reason for the prescription is obesity or weight management.
There is one important qualification. Several of these drugs are also FDA-approved for conditions unrelated to weight loss, and Nebraska Medicaid will cover them for those specific uses.
When Nebraska Medicaid Will Cover a GLP-1
Wegovy (semaglutide) can be approved through prior authorization for two narrow indications. The first is reducing the risk of major adverse cardiovascular events in adults aged 45 to 74 with a history of heart attack, stroke, or symptomatic peripheral arterial disease, along with a BMI of at least 30 (or 27 with a weight-related comorbidity). The second is treating metabolic dysfunction-associated steatohepatitis in adults with moderate to advanced liver fibrosis.3Nebraska Medicaid. Wegovy Prior Authorization Form
Zepbound (tirzepatide) is covered only for moderate-to-severe obstructive sleep apnea in adults with a BMI of at least 30. The patient must have tried and failed positive airway pressure therapy or an oral appliance, and the prescription must come from or in consultation with a sleep specialist.4Nebraska Medicaid. Zepbound Prior Authorization Form
Both approvals require extensive documentation. Patients must have completed at least six months of a medically supervised weight management program that includes behavior modification, a reduced-calorie diet, and increased physical activity. Contraindications that disqualify a patient include a personal or family history of medullary thyroid carcinoma, pregnancy, and concurrent use of another GLP-1 receptor agonist.3Nebraska Medicaid. Wegovy Prior Authorization Form4Nebraska Medicaid. Zepbound Prior Authorization Form
If the underlying reason for the prescription is weight loss itself, none of these pathways apply.
Why the Exclusion Is Allowed
Federal law generally requires state Medicaid programs to cover most FDA-approved outpatient prescription drugs, but a long-standing exception in the Medicaid Drug Rebate Program lets states exclude drugs used for weight loss.5KFF. Medicaid Coverage of and Spending on GLP-1s Nebraska uses that option. The exception does not extend to the drugs’ other FDA-approved uses, which is why cardiovascular, liver, and sleep apnea indications remain reachable through prior authorization.
Other Obesity Coverage Under Nebraska Medicaid
Coverage for obesity treatment more generally is limited. Nutrition counseling is not covered. Intensive behavioral therapy is covered only with limitations and not specifically for obesity, and behavioral assessments and interventions where the sole diagnosis is obesity are not payable.6George Washington University. Nebraska State Snapshot – Medicaid Obesity Coverage7George Washington University. Medicaid Obesity Coverage – Nebraska
Bariatric surgery is covered, with conditions. Procedures must be performed at a designated Center of Excellence, and patients must document prior weight loss attempts, undergo a mental health evaluation, enroll in a weight loss program, and have qualifying comorbid conditions regardless of BMI.6George Washington University. Nebraska State Snapshot – Medicaid Obesity Coverage Covered procedures include gastric bypass, gastric banding, and sleeve gastrectomy. Intragastric balloons and gastric electrical stimulation are excluded as experimental.8UnitedHealthcare. Bariatric Surgery – Nebraska Medicaid
Some Heritage Health managed care plans layer on supplemental weight-related benefits. UnitedHealthcare Community Plan of Nebraska offers Weight Watchers and YMCA memberships to eligible members, and all Heritage Health plans include disease management support for conditions including obesity.9Nebraska DHHS. Heritage Health Plan Comparison Chart 2025 These do not change the drug exclusion.
The 2024 Bill That Would Have Changed This
In February 2024, State Senator Merv Riepe introduced Legislative Bill 907, which would have required Nebraska Medicaid to cover anti-obesity medications and intensive behavioral therapy for obesity treatment.10Nebraska Examiner. Nebraska Lawmaker Seeks to Expand Medicaid Coverage to Include Obesity Dr. Brianna Johnson-Rabbett, testifying for the Nebraska Medical Association, said data from states that already cover the drugs shows only about 1.4% of eligible Medicaid enrollees actually fill the prescriptions.11Becker’s Payer Issues. Nebraska Lawmakers Mull Medicaid Coverage of Weight Loss Drugs
The bill was indefinitely postponed on April 18, 2024, ending it for that session.12Fast Democracy. NE LB 90713CMS. Contract Year 2026 Policy and Technical Changes – Final Rule14American College of Gastroenterology. Anti-Obesity Drugs Will Not Be Covered by Medicare and Medicaid in 2026 Nothing currently forces Nebraska to change its policy.
What This Means Out of Pocket
Without Medicaid coverage, GLP-1 weight loss drugs run upward of $10,000 per year for a patient paying cash.11Becker’s Payer Issues. Nebraska Lawmakers Mull Medicaid Coverage of Weight Loss Drugs For a Nebraska Medicaid enrollee whose only diagnosis is obesity, that is the effective price. The route to coverage runs through one of the narrow non-weight-loss indications above, and it requires a prescriber willing to document the qualifying condition, the six-month supervised weight management history, and the absence of any contraindication.